Skip to main content
. 2021 Jan 25;2021(1):CD012863. doi: 10.1002/14651858.CD012863.pub2

Summary of findings 1. Bethanechol compared to placebo for preventing bladder dysfunction after radical hysterectomy in women with early‐stage cervical cancer.

Comparison 1: Bethanechol versus placebo
Patients: women with early‐stage cervical cancer undergoing radical hysterectomy
Setting: tertiary hospital
Intervention: bethanechol
Comparison: placebo
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI) № of participants
(studies) Certainty of the evidence
(GRADE) Comments
Assumed risk:
placebo
Corresponding risk:
bethanechol
Rate of spontaneous voiding recovery 1 week after surgery Not reported
Quality of life (QoL) Not reported
Time after surgery to post‐void residual volume of urine ≤ 50 mL (days) Not reported
Adverse events Not reported
Post‐void residual urine volume (mL) at 1 month after surgery Mean 98.4 MD 37.4 lower
(60.35 lower to 14.45 lower) 39 participants
(1 RCT) ⊕⊝⊝⊝
Very low a,b  
Urinary tract infections in the first month after surgery Not reported
Subjective urinary symptoms Not reported
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; MD: mean difference; RR: risk ratio
GRADE Working Group grades of evidenceHigh certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect

aThe evidence was downgraded by two levels due to imprecision (combination of sparse data and a low number of events).
bThe evidence was downgraded by one level due to unclear risk of selection bias.